Funded Projects

Explore our currently funded projects. You may search with all three fields, then focus your results by applying any of the dropdown filters. After customizing your search, you may download results and even save your specific search for later.

Reset
Project # Project Title Research Focus Area Research Program Administering IC Institution(s) Investigator(s) Location(s) Year Awarded
3U24DA055325-04S2
The Healthy Brain and Child Development National Consortium Administrative Core Enhanced Outcomes for Infants and Children Exposed to Opioids HEALthy Brain and Child Development Study (HBCD) NIDA UNIVERSITY OF CALIFORNIA SAN DIEGO CHAMBERS, CHRISTINA (contact); NELSON, CHARLES ALEXANDER La Jolla, CA 2024
NOFO Title: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
NOFO Number: PA-20-272
3R33DA057747-04S1
The influence of neighborhood factors and social determinants of health on OUD treatment outcomes Training the Next Generation of Researchers in HEAL NIDA UNIVERSITY OF MARYLAND MAGIDSON, JESSICA F College Park, MD 2024
NOFO Title: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)
NOFO Number: PA-23-189
1R43DA060717-01
Integration of an opioid dispensing, monitoring, and disposal platform with a hospital pharmacy to reduce opioid use by discharged emergency department patients Cross-Cutting Research Small Business Programs NIDA ADDINEX TECHNOLOGIES, INC. ROSLYAKOV, STANISLAV New York, NY 2024
NOFO Title: PHS 2023-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
NOFO Number: PA-23-231
1UG3DA060053-01
Development of a Safer and More Effective Ibogaine Analog for the Treatment of Opioid Use Disorder Novel Therapeutic Options for Opioid Use Disorder and Overdose Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose NIDA GILGAMESH PHARMACEUTICALS, INC. MAREK, GERARD JOSEPH New York, NY 2024
NOFO Title: Development of Medications to Prevent and Treat Opioid and/or Stimulant Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
NOFO Number: PAR-22-200
1R61DA060426-01
Evaluating Vending Machines providing Naloxone to Prevent Overdose in American Indian Communities New Strategies to Prevent and Treat Opioid Addiction NIDA UNIVERSITY OF CALIFORNIA SAN DIEGO GAINES, TOMMI LYNN (contact); KNOX, AMY La Jolla, CA 2024
NOFO Title: Time-Sensitive Opportunities for Health Research (R61/R33 Clinical Trial Not Allowed)
NOFO Number: PAR-22-233
1R01AA031890-01
Advancing Integrated Treatment for Co-Occurring Opioid and Alcohol Use Disorders: A Comprehensive Analysis of GLP-1 Receptor Agonists and Traditional Pharmacotherapies in Real-World Settings Translation of Research to Practice for the Treatment of Opioid Addiction NIAAA LOYOLA UNIVERSITY CHICAGO QEADAN, FARES Maywood, IL 2024
NOFO Title: HEAL Initiative: Developing an Evidence Base for Co-Occurring OUD-AUD Interventions (R01 Clinical Trial Optional)
NOFO Number: RFA-AA-23-005
4R44DA053845-02
Fast-track: Scalable digital delivery of evidence-based training for addiction professionals to maximize treatment admission and retention rates of opioid use disorder in affected families Cross-Cutting Research Small Business Programs NIDA WE THE VILLAGE, INC. MACKY, JANE Brooklyn, NY 2024
NOFO Title: HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Epidemic (R43/R44 - Clinical Trial Optional)
NOFO Number: RFA-DA-19-019
4R33DA057667-02
CADENCE - Continuous And Data-drivEN CarE Cross-Cutting Research Translating Data 2 Action to Prevent Overdose NIDA UNIVERSITY OF SOUTH FLORIDA MARSHALL, JENNIFER (contact); WRIGHT, TANNER Tampa, FL 2024
NOFO Title: HEAL Initiative: HEAL Data2Action Innovation Projects (R61/R33 Clinical Trial Optional)
NOFO Number: RFA-DA-22-051
1R61DA061365-01
An innovative, trauma-informed approach for reducing overdose risk among women re-entering the community from prison Translation of Research to Practice for the Treatment of Opioid Addiction Optimizing the Quality, Reach, and Impact of Addiction Services NIDA UNIVERSITY OF KENTUCKY STATON, MICHELE (contact); KNIGHT, KEVIN Lexington, KY 2024
NOFO Title: HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)
NOFO Number: RFA-DA-23-053
1R61DA062357-01
Strength in HEALing: Indigenous Community-Led Strategies to Treat Stimulant Use Translation of Research to Practice for the Treatment of Opioid Addiction Optimizing the Quality, Reach, and Impact of Addiction Services NIDA WASHINGTON STATE UNIVERSITY HIRCHAK, KATHERINE Pullman, WA 2024
NOFO Title: HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)
NOFO Number: RFA-DA-23-053
1R61DA061723-01
Coalition for harm reduction and prevention (CHRP): Developing and testing a novel Hub and Spoke Model to implement prevention and harm reduction in rural clinics New Strategies to Prevent and Treat Opioid Addiction NIDA UNIVERSITY OF MICHIGAN LIN, LEWEI ALLISON Ann Arbor, MI 2024
NOFO Title: Rural Community-Centered Drug Misuse Prevention and Harm Reduction Research: Addressing Implementation, Dissemination, and Equity Challenges across the Continuum of Care (R61/R33 Clinical Trial Only)
NOFO Number: RFA-DA-24-036
2UM1DA050098-02
Methodology and Advanced Analytics Resource Center 2.0 Translation of Research to Practice for the Treatment of Opioid Addiction Justice Community Opioid Innovation Network (JCOIN) NIDA UNIVERSITY OF CHICAGO SCHNEIDER, JOHN (contact); BREWER, RUSSELL; POLLACK, HAROLD ALEXANDER Chicago, IL 2024
NOFO Title: HEAL Initiative: Justice Community Overdose Innovation Network (JCOIN) - Phase II Methodology and Advanced Analytics Resource Center (UM1 Clinical Trial Not Allowed)
NOFO Number: RFA-DA-24-068
2UG1HD104251-02
UAB Outcomes of Babies with Opioid Exposure (OBOE study) Enhanced Outcomes for Infants and Children Exposed to Opioids Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) NICHD UNIVERSITY OF ALABAMA AT BIRMINGHAM AMBALAVANAN, NAMASIVAYAM (contact); PERALTA-CARCELEN, ADA MYRIAM Birmingham, AL 2024
NOFO Title: HEAL Initiative: Limited Competition: Clinical Centers for Completion of the Outcomes of Babies with Opioid Exposure (OBOE) Study (UG1 Clinical Trial Not Allowed)
NOFO Number: RFA-HD-24-014
4UF1MH121944-02
The Whole Health Study: Collaborative Care for OUD and Mental Health Conditions New Strategies to Prevent and Treat Opioid Addiction Optimizing Care for People with Opioid Use Disorder and Mental Health Conditions NIMH UNIVERSITY OF PENNSYLVANIA MANDELL, DAVID S (contact); BOGNER, HILLARY R; KAMPMAN, KYLE MATTHEW Philadelphia, PA 2024
NOFO Title: HEAL Initiative: Effectiveness Trials to Optimize, Implement, Scale, and Sustain the Collaborative Care Model for Individuals with Opioid Use Disorders and Mental Health Conditions (U01 Clinical Trial)
NOFO Number: RFA-MH-19-525
3OT2OD031940-01S3
A Strategy for Heal Federated Data Ecosystem Cross-Cutting Research OD UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL GOSWAMI, SUPARNA Chapel Hill, NC 2024
NOFO Title: HEAL data coordination and research platform (Data Corp)
NOFO Number: OTA-21-002
1OT2DA061111-01
AASTEC-AAIHB N CREW Program Translation of Research to Practice for the Treatment of Opioid Addiction Native Collective Research Effort to Enhance Wellness (N CREW) Program: Addressing Overdose, Substance Use, Mental Health, and Pain NIDA ALBUQUERQUE AREA INDIAN HEALTH BOARD ENGLISH, KEVIN CHARLES (contact); POOLA, CHARLENE Albuquerque, NM 2024
NOFO Title: HEAL Initiative: Native Collective Research Effort to Enhance Wellness (N CREW) Program - Addressing Overdose, Substance Use, Mental Health, and Pain (OT2)
NOFO Number: OTA-23-007
1OT2DA062972-01
Increasing the Capacity of a Community-Based Research Center to Address Opioid Use Disorder and Related Health Inequities in Urban American Indian Communities Translation of Research to Practice for the Treatment of Opioid Addiction Native Collective Research Effort to Enhance Wellness (N CREW) Program: Addressing Overdose, Substance Use, Mental Health, and Pain NIDA NATIVE AMERICAN COMMUNITY CLINIC STATELY, ANTONY Minneapolis, MN 2024
NOFO Title: HEAL Initiative: Native Collective Research Effort to Enhance Wellness (N CREW) Program - Addressing Overdose, Substance Use, Mental Health, and Pain (OT2)
NOFO Number: OTA-23-007
1R01DA058640-01A1
Improving Perioperative Care for Patients with Opioid Use Disorder New Strategies to Prevent and Treat Opioid Addiction NIDA UNIVERSITY OF MICHIGAN BICKET, MARK (contact); WALJEE, JENNIFER FILIP Ann Arbor, MI 2024
NOFO Title: Research Project Grant (Parent R01 Clinical Trial Required)
NOFO Number: PA-20-183
3UG1DA050072-05S1
TCN PATHS Supplemental funding Translation of Research to Practice for the Treatment of Opioid Addiction Justice Community Opioid Innovation Network (JCOIN) NIDA YALE UNIVERSITY WANG, EMILY AI-HUA New Haven, CT 2024
NOFO Title: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
NOFO Number: PA-20-272
3R01DA057668-01S1
Enhancing Precision in Overdose Mortality Prediction through Data Linkage: A Heterogeneous Capture-Recapture Approach to Estimating Opioid Use Disorder Prevalence in Ohio Cross-Cutting Research Leveraging Existing and Real-Time Opioid and Pain Management Data NIDA OHIO STATE UNIVERSITY FERNANDEZ, SOLEDAD A (contact); FAREED, NALEEF Columbus, OH 2024
NOFO Title: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
NOFO Number: PA-20-272
1R43DA058603-01A1
Developing a novel epigenetic regulator as a treatment for opioid use disorder Cross-Cutting Research Small Business Programs NIDA EPIVARIO, LLC KIM, THOMAS Philadelphia, PA 2024
NOFO Title: PHS 2022-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
NOFO Number: PA-22-176
3U01DA055355-04S1
9/24- Healthy Brain and Child Development National Consortium Training the Next Generation of Researchers in HEAL NIDA NORTHWESTERN UNIVERSITY CHICAGO WAKSCHLAG, LAUREN S (contact); NORTON, ELIZABETH SPENCER Chicago, IL 2024
NOFO Title: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)
NOFO Number: PA-23-189
4UH3DA054825-03
A novel and highly selective orexin 1 receptor antagonist for the treatment of patients with opioid use disorder. Novel Therapeutic Options for Opioid Use Disorder and Overdose Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose NIDA ASTRAZENECA PHARMACEUTICALS, LP GURRELL, IAN Wilmington, DE 2024
NOFO Title: Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trial Optional)
NOFO Number: PAR-20-092
1U01DA059994-01
Efficacy, safety, and pharmacokinetic study of BICX104 naltrexone subcutaneous implant alone and in combination with bupropion for the treatment of Methamphetamine Use Disorder (MUD). Novel Therapeutic Options for Opioid Use Disorder and Overdose Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose NIDA BIOCORRX PHARMACEUTICALS, INC. DEVARNEY, KATE BEEBE Anaheim, CA 2024
NOFO Title: Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
NOFO Number: PAR-22-202
1K01DA061078-01
Reducing opioid misuse among urban Indigenous young adults in Montana using a culturally centered intervention Training the Next Generation of Researchers in HEAL NIDA UNIVERSITY OF MONTANA CHASE-BEGAY, DAMIAN M Missoula, MT 2024
NOFO Title: HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K01 - Clinical Trial Required)
NOFO Number: PAS-22-206